Carl Zeiss Meditec (CZM) is the company who developed and presented the first excimer laser for refractive surgery already in 1986.
ZEISS is not only a pioneer, but a real innovator in the development of advanced devices, procedures and services for the treatment of refractive disorders. As an innovation leader in corneal and refractive surgery the company and its employees have a pronounced sense for high-potential system solutions and future trends.
Unique laser vision correction solutions such as ReLEx® SMILE and PRESBYOND® Laser Blended Vision and the treatment planning tool CRS-Master® enable you to select the best possible treatment option for every patient in order to achieve excellent clinical results and maximum patient satisfaction.
With the VisuMax® femtosecond system, the MEL® 80 and the MEL 90 excimer laser, ZEISS provides the most comprehensive range of the latest laser refractive surgery solutions. These enable you to perform state-of-the-art Femto-LASIK and other traditional laser vision correction and therapeutic procedures (e. g. Keratoplasty and Incision for ICR). Additionally VisuMax creates new opportunities with the unique treatment option ReLEx SMILE. It is the first minimally invasive, flapless SMILE solution for performing small incision lenticule extraction.
CRS-Master is the ideal complementary treatment planning tool that integrates patient and diagnostic data for customized visual correction using the MEL 80 and MEL 90. This includes topography-guided treatment as well as the unique age-optimized PRESBYOND Laser Blended Vision.
With ATLAS® 9000, ZEISS provides an established and highly advanced diagnostic system. In combination with the CRS-Master planning tool it provides the best basis for customized treatments in laser vision correction with excimer laser MEL 80 and MEL 90. When it comes to routine diagnostic examinations of anterior segment, vitreous or fundus, the ZEISS Slit Lamp portfolio is the first choice in optical performance and optimized operations.